[
  {
    "ts": "2025-06-19T11:38:20+00:00",
    "headline": "Biogen starts dosing in Phase III trial of Friedreich ataxia therapy",
    "summary": "The trial aims to assess the safety, pharmacodynamics, efficacy, and pharmacokinetics of the therapy in nearly 255 subjects.",
    "url": "https://www.clinicaltrialsarena.com/news/biogen-trial-friedreich-ataxia/",
    "source": "Clinical Trials Arena",
    "provider": "yfinance",
    "raw": {
      "id": "bf93dc3e-76b6-3019-b203-e187b7707ab4",
      "content": {
        "id": "bf93dc3e-76b6-3019-b203-e187b7707ab4",
        "contentType": "STORY",
        "title": "Biogen starts dosing in Phase III trial of Friedreich ataxia therapy",
        "description": "",
        "summary": "The trial aims to assess the safety, pharmacodynamics, efficacy, and pharmacokinetics of the therapy in nearly 255 subjects.",
        "pubDate": "2025-06-19T11:38:20Z",
        "displayTime": "2025-06-19T11:38:20Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/clinical_trials_arena_396/a82650bab95ce80cfb422bc219af5e9f",
          "originalWidth": 1440,
          "originalHeight": 810,
          "caption": "Biogenâ€™s omaveloxolone is approved to treat Friedreich ataxia in more than 40 nations. Credit: JHVEPhoto / Shutterstock.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wUL83w6E.GQhu05Ge3hsEw--~B/aD04MTA7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/clinical_trials_arena_396/a82650bab95ce80cfb422bc219af5e9f.cf.webp",
              "width": 1440,
              "height": 810,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AuBrOKoeqJhJThFMqBvs6w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/clinical_trials_arena_396/a82650bab95ce80cfb422bc219af5e9f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Clinical Trials Arena",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.clinicaltrialsarena.com/news/biogen-trial-friedreich-ataxia/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/biogen-starts-dosing-phase-iii-113820899.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BIIB"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]